Kidney Failure, Chronic

• 

  Subject Areas on Research

  • A 55-year-old man with fever, renal failure, and hip pain. 
  • A Cascade of Structural Barriers Contributing to Racial Kidney Transplant Inequities. 
  • A Pilot Randomized Trial of Ferric Citrate Coordination Complex for the Treatment of Advanced CKD. 
  • A Prospective Cohort Study of Mineral Metabolism After Kidney Transplantation. 
  • A comparison between the HeRO graft and conventional arteriovenous grafts in hemodialysis patients. 
  • A comparison of HIV-positive patients with and without infective endocarditis: an echocardiographic study--the Emory Endocarditis Group experience. 
  • A forgotten vascular technique in renal transplantation. 
  • A multi-dose pharmacokinetic study of dalteparin in haemodialysis patients. 
  • A new locus for familial FSGS on chromosome 2p. 
  • A patient with end-stage renal disease and a neck mass. 
  • A prospective, randomized, multicenter study evaluating early corticosteroid withdrawal with Thymoglobulin in living-donor kidney transplantation. 
  • A quantitative histomorphometric comparison of 40 micron thick Paragon sections with 5 micron thick Goldner sections in the study of undecalcified bone. 
  • A randomized, placebo-controlled phase I trial of live, attenuated herpes zoster vaccine in subjects with end-stage renal disease immunized prior to renal transplantation. 
  • ACE inhibitors do not affect erythropoietin efficacy in haemodialysis patients. 
  • ASN End-Stage Renal Disease Task Force: perspective on prospective payments for renal dialysis facilities. 
  • Abnormally elevated serum hCG in a patient with end-stage renal disease seeking abortion: to be expected or a cause for concern? A case report. 
  • Achalasia symptom response after Heller myotomy segregated by high-resolution manometry subtypes. 
  • Acute kidney injury in older adults. 
  • Addressing guideline and policy changes during pragmatic clinical trials. 
  • Addressing the challenges of sleeve gastrectomy in end-stage renal disease: Analysis of 100 consecutive renal failure patients. 
  • Adherence to Healthy Dietary Patterns and Risk of CKD Progression and All-Cause Mortality: Findings From the CRIC (Chronic Renal Insufficiency Cohort) Study. 
  • Adiposity and risk of decline in glomerular filtration rate: meta-analysis of individual participant data in a global consortium. 
  • Adjunctive agents in systemic chemotherapy. 
  • Adolescents' perception of living with end stage renal disease 
  • Advance care planning with patients on hemodialysis: an implementation study. 
  • Affective psychoses following renal transplant. 
  • Age and comorbidities are effect modifiers of gender disparities in renal transplantation. 
  • Alterations in soluble and leukocyte surface L-selectin (CD 62L) in hemodialysis patients. 
  • American Society of Pediatric Nephrology position paper on linking reimbursement to quality of care. 
  • Amphotericin B therapy in an anephric patient. 
  • An observational study on the epidemiological and mycological profile of Candidemia in ICU patients. 
  • Anaemia of CKD--the CHOIR study revisited. 
  • Analysis of Respiratory Fluoroquinolones and the Risk of Sudden Cardiac Death Among Patients Receiving Hemodialysis. 
  • Anemia as a risk factor and therapeutic target in heart failure. 
  • Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data. 
  • Annual wellness visits and care management before and after dialysis initiation. 
  • Anti-Leukocyte Function-Associated Antigen 1 Therapy in a Nonhuman Primate Renal Transplant Model of Costimulation Blockade-Resistant Rejection. 
  • Anticoagulant Use Among Patients With End-Stage Renal Disease Undergoing Percutaneous Coronary Intervention: An Analysis From the National Cardiovascular Data Registry. 
  • Antihypertensive medications and risk of death and hospitalizations in US hemodialysis patients: Evidence from a cohort study to inform hypertension treatment practices. 
  • Aorto-coronary bypass graft surgery in a patient on home hemodialysis. 
  • Apixaban for Patients With Atrial Fibrillation on Hemodialysis: A Multicenter Randomized Controlled Trial. 
  • Apparent recurrence of progressive systemic sclerosis in a renal allograft. 
  • Application of a Novel CT-Based Iliac Artery Calcification Scoring System for Predicting Renal Transplant Outcomes. 
  • Arterial compliance in adolescents and young adults receiving chronic hemodialysis. 
  • Arterial homeostasis, inflammation, and erythropoietic growth factors. 
  • Arteriovenous Graft Delamination and Dissection as a Cause of Graft Dysfunction. 
  • Arteriovenous Graft Failure in the Veterans Health Administration: Outcome Disparities Associated with Race. 
  • Aspiration of the asymptomatic metatarsophalangeal joint in gout patients and hyperuricemic controls. 
  • Association Between Chronic Kidney Disease and Rates of Transfusion and Progression to End-Stage Renal Disease in Patients Undergoing Transradial Versus Transfemoral Cardiac Catheterization-An Analysis From the Veterans Affairs Clinical Assessment Reporting and Tracking (CART) Program. 
  • Association between body mass index and chronic kidney disease in men and women: population-based study of Malay adults in Singapore. 
  • Association between high-dose erythropoiesis-stimulating agents, inflammatory biomarkers, and soluble erythropoietin receptors. 
  • Association between pulse pressure and mortality in patients undergoing maintenance hemodialysis. 
  • Association of Nondisease-Specific Problems with Mortality, Long-Term Care, and Functional Impairment among Older Adults Who Require Skilled Nursing Care after Dialysis Initiation. 
  • Association of Opioids and Nonsteroidal Anti-inflammatory Drugs With Outcomes in CKD: Findings From the CRIC (Chronic Renal Insufficiency Cohort) Study. 
  • Association of Race and Ethnicity With Live Donor Kidney Transplantation in the United States From 1995 to 2014. 
  • Association of Serious Fall Injuries among United States End Stage Kidney Disease Patients with Access to Kidney Transplantation. 
  • Association of Social Risk Factors With Home Dialysis and Kidney Transplant Rates in Dialysis Facilities. 
  • Association of VA Payment Reform for Dialysis with Spending, Access to Care, and Outcomes for Veterans with ESKD. 
  • Association of blood pressure increases during hemodialysis with 2-year mortality in incident hemodialysis patients: a secondary analysis of the Dialysis Morbidity and Mortality Wave 2 Study. 
  • Association of insurance status with timing of hemodialysis access placement. 
  • Association of intradialytic blood pressure changes with hospitalization and mortality rates in prevalent ESRD patients. 
  • Association of serum bicarbonate with risk of renal and cardiovascular outcomes in CKD: a report from the Chronic Renal Insufficiency Cohort (CRIC) study. 
  • Association of serum calcitonin with coronary artery disease in individuals with and without chronic kidney disease. 
  • Asterixis mimicking drop attacks in chronic renal failure. 
  • Atrial Fibrillation and Risk of ESRD in Adults with CKD. 
  • Authors' Reply. 
  • Automated external defibrillators and survival from cardiac arrest in the outpatient hemodialysis clinic. 
  • BP Control and Long-Term Risk of ESRD and Mortality. 
  • Back off baclofen when the kidneys don't work. 
  • Baclofen Toxicity in Kidney Disease. 
  • Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease. 
  • Belatacept Combined With Transient Calcineurin Inhibitor Therapy Prevents Rejection and Promotes Improved Long-Term Renal Allograft Function. 
  • Beta-lactam antibiotic-induced pseudoporphyria. 
  • Beyond minerals and parathyroid hormone: role of active vitamin D in end-stage renal disease. 
  • Bilateral retroperitoneal renal allografts: technique for placement through a midline incision. 
  • Bioengineered human acellular vessels for dialysis access in patients with end-stage renal disease: two phase 2 single-arm trials. 
  • Biology of vascular calcification in renal disease. 
  • Biomarkers of vascular calcification and mortality in patients with ESRD. 
  • Biopsychosocial experiences and coping strategies of elderly ESRD patients: a qualitative study to inform the development of more holistic and person-centred health services in Singapore. 
  • Blunted cyclic variation of heart rate predicts mortality risk in post-myocardial infarction, end-stage renal disease, and chronic heart failure patients. 
  • CD57(+) CD4 T Cells Underlie Belatacept-Resistant Allograft Rejection. 
  • Calciphylaxis. 
  • Calciphylaxis: a poor prognostic indicator for limb salvage. 
  • Can We Cure Light Chain Deposition Disease of the Kidneys?-A Review and Case Report of a Patient Treated With a Triple Transplant Approach. 
  • Candida fasciitis following renal transplantation. 
  • Carboplatin-based chemotherapy with pharmacokinetic analysis for patients with hemodialysis-dependent renal insufficiency. 
  • Cardiac diseases in maintenance hemodialysis patients: results of the HEMO Study. 
  • Cardiovascular Outcomes Reported in Hemodialysis Trials. 
  • Care of the Pediatric Patient on Chronic Dialysis. 
  • Care of the pediatric patient on chronic peritoneal dialysis. 
  • Care of the undocumented immigrant in the United States with ESRD. 
  • Catheter access for hemodialysis: an overview. 
  • Cause Unknown, Treatment Uncertain, Outcome Poor: An Encounter With Kidney Failure in the Developing World. 
  • Causes of death in renal transplant recipients. A review of autopsy findings from 1966 through 1985. 
  • Changes in Urinary Microbiome Populations Correlate in Kidney Transplants With Interstitial Fibrosis and Tubular Atrophy Documented in Early Surveillance Biopsies. 
  • Characteristics of treated hypertension in incident hemodialysis and peritoneal dialysis patients. 
  • Chronic kidney disease after hematopoietic cell transplantation: a systematic review. 
  • Chronic kidney disease and intraocular pressure: the Singapore Malay Eye Study. 
  • Chronic kidney disease in HIV infection: an urban epidemic. 
  • Chronic kidney disease in patients with non-ST-segment elevation acute coronary syndromes. 
  • Chronic kidney disease, mortality, and treatment strategies among patients with clinically significant coronary artery disease. 
  • Chronic organizing microangiopathy in a renal transplant recipient. 
  • Chronic renal failure in infants and children. 
  • Chronic renal insufficiency in infants and children. 
  • Clinical Outcomes in Dialysis Patients: Prospects for Improvement with Aldosterone Receptor Antagonists. 
  • Clinical Outcomes of Arteriovenous Access in Incident Hemodialysis Patients with Medicare Coverage, 2012-2014. 
  • Clinical and pharmacokinetic profiles of digoxin immune Fab in four patients with renal impairment. 
  • Clinical events and patient-reported outcome measures during CKD progression: findings from the Chronic Renal Insufficiency Cohort Study. 
  • Clinical experience with human anodal trypsinogen (HAT) for detection of pancreatic allograft rejection. 
  • Clinical outcome of interval cadaveric renal transplantation in cardiac allograft recipients. 
  • Clinical outcomes and costs due to Staphylococcus aureus bacteremia among patients receiving long-term hemodialysis. 
  • Clinical problem-solving. Index of suspicion. 
  • Clinical studies of hemodialysis access through formaldehyde-fixed arterial allografts. 
  • Clinical, biochemical and pathological predictors of poor response to intravenous cyclophosphamide in patients with proliferative lupus nephritis. 
  • Cockcroft-Gault versus modification of diet in renal disease: importance of glomerular filtration rate formula for classification of chronic kidney disease in patients with non-ST-segment elevation acute coronary syndromes. 
  • Collapsing glomerulopathy in 19 patients with systemic lupus erythematosus or lupus-like disease. 
  • Combined liver-kidney and liver transplantation in patients with renal failure outcomes in the MELD era. 
  • Comparative Efficacy of Coronary Revascularization Procedures for Multivessel Coronary Artery Disease in Patients With Chronic Kidney Disease. 
  • Comparative effectiveness studies to improve clinical outcomes in end stage renal disease: the DEcIDE patient outcomes in end stage renal disease study. 
  • Comparative health services research across populations: the unused opportunities in big data. 
  • Comparative outcomes of predominant facility-level use of ferumoxytol versus other intravenous iron formulations in incident hemodialysis patients. 
  • Comparing Kidney Health Outcomes in Children, Adolescents, and Adults With Focal Segmental Glomerulosclerosis. 
  • Comparing Mortality of Peritoneal and Hemodialysis Patients in an Era of Medicare Payment Reform. 
  • Comparing Presenting Clinical Features in 48 Children With Microscopic Polyangiitis to 183 Children Who Have Granulomatosis With Polyangiitis (Wegener's): An ARChiVe Cohort Study. 
  • Comparing the Palliative Care Needs of Those With Cancer to Those With Common Non-Cancer Serious Illness. 
  • Comparison of life participation activities among adults treated by hemodialysis, peritoneal dialysis, and kidney transplantation: a systematic review. 
  • Comparison of risk and age at diagnosis of myocardial infarction, end-stage renal disease, and non-AIDS-defining cancer in HIV-infected versus uninfected adults. 
  • Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate. 
  • Competing Risk of Death With End-Stage Renal Disease in Diabetic Kidney Disease. 
  • Complete Chain of the First Global Kidney Exchange Transplant and 3-yr Follow-up 
  • Complete Remission in the Nephrotic Syndrome Study Network. 
  • Concerns regarding the financial aspects of kidney transplantation: perspectives of pre-transplant patients and their family members. 
  • Consumption of Coffee but Not of Other Caffeine-Containing Beverages Reduces the Risk of End-Stage Renal Disease in the Singapore Chinese Health Study. 
  • Contrast nephrotoxicity: a randomized controlled trial of a nonionic and an ionic radiographic contrast agent. 
  • Coping strategies utilized by adolescents with end stage renal disease 
  • Coping with fluid restriction and the quality of life in hemodialysis patients with very low or no daily urine output. 
  • Coronary artery bypass grafting in patients with dialysis-dependent renal failure. 
  • Cost-effectiveness of the oral adsorbent AST-120 versus placebo for chronic kidney disease. 
  • Costs and outcomes among hemodialysis-dependent patients with methicillin-resistant or methicillin-susceptible Staphylococcus aureus bacteremia. 
  • CureGN Study Rationale, Design, and Methods: Establishing a Large Prospective Observational Study of Glomerular Disease. 
  • Cyclosporine nephrotoxicity in cardiac allograft patients--a seven-year follow-up. 
  • Cytokine polymorphic analyses indicate ethnic differences in the allelic distribution of interleukin-2 and interleukin-6. 
  • Death or hospitalization of patients on chronic hemodialysis is associated with a physician-based diagnosis of depression. 
  • Declining influence of race on the outcome of living-donor renal transplantation. 
  • Decreased incidence of end-stage renal disease in American Indians with diabetes: a model for other high-risk populations? 
  • Decreased pulse pressure during hemodialysis is associated with improved 6-month outcomes. 
  • Delivery of a patient-friendly functioning report to improve patient-centeredness of dialysis care: a pilot study. 
  • Depression as a potential explanation for gender differences in health-related quality of life among patients on maintenance hemodialysis. 
  • Design and Rationale of HiLo: A Pragmatic, Randomized Trial of Phosphate Management for Patients Receiving Maintenance Hemodialysis. 
  • Detection of Donor's HIV Strain in HIV-Positive Kidney-Transplant Recipient. 
  • Determinants of peritoneal dialysis technique failure in incident US patients. 
  • Determinants of regret in elderly dialysis patients. 
  • Development, implementation and user experience of the Veterans Health Administration (VHA) dialysis dashboard. 
  • Diabetic nephropathy: a national dialogue. 
  • Diagnosis and management of mineral metabolism in CKD. 
  • Dialysate Potassium, Dialysate Magnesium, and Hemodialysis Risk. 
  • Dialysate and blood flow dependence of diffusive solute clearance during CVVHD. 
  • Dialysate potassium concentration: Should mass balance trump electrophysiology? 
  • Dialysis Facility Profit Status and Early Steps in Kidney Transplantation in the Southeastern United States. 
  • Dialysis facility referral and start of evaluation for kidney transplantation among patients treated with dialysis in the Southeastern United States. 
  • Dialysis or transplantation: fitting the treatment to the patient. 
  • Diarrhea in a Patient With Combined Kidney-Pancreas Transplant. 
  • Dietary phosphorus restriction in advanced chronic kidney disease: merits, challenges, and emerging strategies. 
  • Differences in access to kidney transplantation between Hispanic and non-Hispanic whites by geographic location in the United States. 
  • Differential effects of donor-specific alloantibody. 
  • Digoxin measurements following plasma ultrafiltration in two patients with digoxin toxicity treated with specific Fab fragments. 
  • Directed use of the internet for health information by patients with chronic kidney disease: prospective cohort study. 
  • Disparities in worldwide treatment of kidney failure. 
  • Disseminated infection with rapidly growing mycobacteria. 
  • Do cardiac troponins provide prognostic insight in hemodialysis patients? 
  • Do income level and race influence survival in patients receiving hemodialysis? 
  • Donation after cardiac death: the University of Wisconsin experience with liver transplantation. 
  • Donor-Derived Neuroendocrine Carcinoma Transmission to Two Kidney Transplant Recipients Demonstrated by Short Tandem Repeat Analysis: A Case Report. 
  • Dual RAAS blockade for kidney failure: hope for the future. 
  • ESRD: pay now or pay later. 
  • Early infection risk with primary versus staged Hemodialysis Reliable Outflow (HeRO) graft implantation. 
  • Effect of Etelcalcetide vs Cinacalcet on Serum Parathyroid Hormone in Patients Receiving Hemodialysis With Secondary Hyperparathyroidism: A Randomized Clinical Trial. 
  • Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal Risk: The CARMELINA Randomized Clinical Trial. 
  • Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. 
  • Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis. 
  • Effect of dialysate composition on the lipid response to L-carnitine supplementation. 
  • Effect of intravenous iron use on hospitalizations in patients undergoing hemodialysis: a comparative effectiveness analysis from the DEcIDE-ESRD study. 
  • Effect of primary care physicians' use of estimated glomerular filtration rate on the timing of their subspecialty referral decisions. 
  • Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial. 
  • Effects of Linagliptin on Cardiovascular and Kidney Outcomes in People With Normal and Reduced Kidney Function: Secondary Analysis of the CARMELINA Randomized Trial. 
  • Efficiency and outcomes of emergent vascular access procedures performed at a dedicated outpatient vascular access center. 
  • Elevated Donor Hemoglobin A1C Impairs Kidney Graft Survival From Deceased Donors With Diabetes Mellitus: A National Analysis. 
  • Enalapril and hydroxyurea therapy for children with sickle nephropathy. 
  • End-stage renal disease and intensive care unit prognosis: are current tools good enough? 
  • End-stage renal disease in nursing homes: a systematic review. 
  • End-stage renal disease treatment options education: What matters most to patients and families. 
  • Epidemiology of drug-disease interactions in older veteran nursing home residents. 
  • Ethnicity greatly influences cytokine gene polymorphism distribution. 
  • Evaluation and Active Treatment versus Active Surveillance of Localized Prostate Cancer in Renal Transplant Patients in the Era of Low and Very Low Risk Prostate Cancer. 
  • Evaluation of Variation in the Performance of GFR Slope as a Surrogate End Point for Kidney Failure in Clinical Trials that Differ by Severity of CKD. 
  • Evaluation of disease-state management of dialysis patients. 
  • Evidence basis for integrated management of mineral metabolism in patients with end-stage renal disease. 
  • Exacerbation of radiocontrast nephrotoxicity by endothelin receptor antagonism. 
  • Examination of Potential Modifiers of the Association of APOL1 Alleles with CKD Progression. 
  • Extended epoetin alfa dosing as maintenance treatment for the anemia of chronic kidney disease: the PROMPT study. 
  • FGF-23: More than a regulator of renal phosphate handling? 
  • FGF23 induces left ventricular hypertrophy. 
  • Factors associated with failure to list HIV-positive kidney transplant candidates. 
  • Factors influencing postoperative adverse events after Hartmann's reversal. 
  • Falling into the doughnut hole: drug spending among beneficiaries with end-stage renal disease under Medicare Part D plans. 
  • Familial hyperuricemia and renal insufficiency. 
  • Familial hypocalciuric hypercalcemia in the donor and recipient of a living related donor kidney transplant. 
  • Family dynamics in a multi-ethnic Asian society: comparison of elderly CKD patients and their family caregivers experience with medical decision making for managing end stage kidney disease. 
  • Feasibility and acceptability of the TALK social worker intervention to improve live kidney transplantation. 
  • Feasibility and benefits of exercise training in patients on maintenance dialysis. 
  • Fenoldopam mesylate for the prevention of contrast-induced nephropathy: a randomized controlled trial. 
  • Fibrin sealant improves hemostasis in peripheral vascular surgery: a randomized prospective trial. 
  • Fibroblast Growth Factor 23 Trajectories in Chronic Hemodialysis Patients: Lessons from the HEMO Study. 
  • Fibroblast Growth Factor 23 and Kidney Disease Progression in Autosomal Dominant Polycystic Kidney Disease. 
  • Fibroblast Growth Factor-23 Fans the Flames of Heart and Kidney Failure. 
  • Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. 
  • Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease. 
  • Fibroblast growth factor 23 in patients undergoing peritoneal dialysis. 
  • Fibroblast growth factor receptor 4: the missing link between chronic kidney disease and FGF23-induced left ventricular hypertrophy? 
  • Fibroblast growth factor-23 and cardiovascular events in CKD. 
  • Fludarabine-based nonmyeloablative stem cell transplantation for sickle cell disease with and without renal failure: clinical outcome and pharmacokinetics. 
  • Focal segmental glomerulosclerosis: a need for caution in live-related renal transplantation. 
  • Fragmentation of care as a barrier to optimal ESKD management. 
  • Freestanding Dialysis Facility Quality Incentive Program Scores and Mortality Among Incident Dialysis Patients in the United States. 
  • Functional Characteristics and Phenotypic Plasticity of CD57+PD1- CD4 T Cells and Their Relationship with Transplant Immunosuppression. 
  • Genetic association for renal traits among participants of African ancestry reveals new loci for renal function. 
  • Genome-wide association and functional follow-up reveals new loci for kidney function. 
  • Geographic and temporal trends in peritoneal dialysis services in the United States between 1995 and 2003. 
  • Geographic variation in CKD prevalence and ESRD incidence in the United States: results from the reasons for geographic and racial differences in stroke (REGARDS) study. 
  • Geospatial Analysis of Organ Transplant Referral Regions. 
  • Global glomerulosclerosis with nephrotic syndrome; the clinical importance of age adjustment. 
  • Glycemic status, non-traditional risk and left ventricular structure and function in the Jackson Heart Study. 
  • Gone but not forgotten: resolution of childhood kidney disease and the risk of end-stage kidney disease in adults. 
  • Graft loss due to recurrent focal segmental glomerulosclerosis in renal transplant recipients in the United States. 
  • HIV and the kidney: a spotlight on racial disparities. 
  • HIV in the dialysis population: Current issues and future directions. 
  • HIV-1 induces renal epithelial dedifferentiation in a transgenic model of HIV-associated nephropathy. 
  • HIV-1 viral protein r induces ERK and caspase-8-dependent apoptosis in renal tubular epithelial cells. 
  • Have racial disparities in home dialysis utilization changed over time? 
  • Health Education and General Practitioner Training in Hypertension Management: Long-Term Effects on Kidney Function. 
  • Healthful dietary patterns and risk of end-stage kidney disease: the Singapore Chinese Health Study. 
  • Heart disease and stroke statistics--2011 update: a report from the American Heart Association. 
  • Hemodialysis Disparities in African Americans: The Deeply Integrated Concept of Race in the Social Fabric of Our Society. 
  • Hemodialysis Reliable Outflow device impingement in the subclavian position: a case report. 
  • Hemodynamic changes during dialysis. 
  • Hemoperitoneum complicating chronic peritoneal dialysis: single-center experience and literature review. 
  • Hemorrhagic Herpes Simplex Virus Type 1 Nephritis: An Unusual Cause of Acute Allograft Dysfunction. 
  • Hepatic and pancreatic resection in patients with end-stage renal disease: a propensity analysis. 
  • Hepatitis B vaccines in patients with chronic renal failure before dialysis. 
  • Hereditary thrombotic thrombocytopenic purpura: microangiopathic hemolytic anemia, thrombocytopenia, and renal insufficiency occurring in consecutive generations. 
  • Highly active antiretroviral therapy and the epidemic of HIV+ end-stage renal disease. 
  • Hispanic ethnicity and vascular access use in patients initiating hemodialysis in the United States. 
  • Homocysteine-lowering and cardiovascular disease outcomes in kidney transplant recipients: primary results from the Folic Acid for Vascular Outcome Reduction in Transplantation trial. 
  • Horseshoe kidney transplantation. 
  • Hospital readmissions following HLA-incompatible live donor kidney transplantation: A multi-center study. 
  • Hospitalizations for bacterial septicemia after renal transplantation in the united states. 
  • Hypercalcemia in a dialysis patient. 
  • Hypercalcemia in patients with advanced chronic renal failure not yet requiring dialysis. 
  • Hypercalcemia. A complication of advanced chronic liver disease. 
  • Hypercholesterolemia in rats with chronic renal insufficiency not aggravated by recombinant human growth hormone. 
  • Hypercoagulable states and antithrombotic strategies in recurrent vascular access site thrombosis. 
  • Hyperkalemia associated with intravenous labetalol therapy for acute hypertension in renal transplant recipients. 
  • Hyperlipidemia and transplantation: etiologic factors and therapy. 
  • Hyperparathyroidism and 1,25-dihydroxyvitamin D deficiency in mild, moderate, and severe renal failure. 
  • Hypertension and albuminuria in chronic kidney disease mapped to a mouse chromosome 11 locus. 
  • Hypertension, chronic kidney disease, and the development of cardiovascular risk: a joint primacy. 
  • Hypertension, hypertension control, and chronic kidney disease in a Malay population in Singapore. 
  • Hypokalemia and outcomes in patients with chronic heart failure and chronic kidney disease: findings from propensity-matched studies. 
  • Iatrogenic Baclofen Neurotoxicity in ESRD: Recognition and Management. 
  • Identification of calcium oxalate crystals using alizarin red S stain. 
  • Ignorance of hedonic adaptation to hemodialysis: a study using ecological momentary assessment. 
  • Impact of Medicare coverage on disparities in access to simultaneous pancreas and kidney transplantation. 
  • Impact of activated vitamin D and race on survival among hemodialysis patients. 
  • Impact of acute kidney injury on chronic kidney disease and its progression. 
  • Impact of donor and recipient age difference on long-term allograft survival after living donor renal transplantation: analysis of 478 cases. 
  • Impact of poverty on serum phosphate concentrations in the Third National Health and Nutrition Examination Survey. 
  • Impact of pre-dialysis nephrology care engagement and decision-making on provider and patient action toward permanent vascular access. 
  • Impact of preoperative renal dysfunction in patients undergoing off-pump versus on-pump coronary artery bypass. 
  • Impacts of Geographic Distance on Peritoneal Dialysis Utilization: Refining Models of Treatment Selection. 
  • Impaired muscle oxygen metabolism in uremic children: improved after renal transplantation. 
  • Implementation of standardized follow-up care significantly reduces peritonitis in children on chronic peritoneal dialysis. 
  • Improvement of Recalcitrant Diabetic Macular Edema After Peritoneal Dialysis. 
  • Improving ascertainment of sudden cardiac death in patients with end stage renal disease. 
  • Improving survival of octogenarian patients selected for haemodialysis. 
  • In-Hospital Cardiac Arrest Resuscitation Practices and Outcomes in Maintenance Dialysis Patients. 
  • In-hospital and 1-year outcomes among percutaneous coronary intervention patients with chronic kidney disease in the era of drug-eluting stents: a report from the EVENT (Evaluation of Drug Eluting Stents and Ischemic Events) registry. 
  • Incidence and long-term significance of transient ST segment deviation in hemodialysis patients. 
  • Incident ESRD and treatment-resistant hypertension: the reasons for geographic and racial differences in stroke (REGARDS) study. 
  • Incidental findings on cardiac computed tomography in incident hemodialysis patients: the predictors of arrhythmic and cardiovascular events in end-stage renal disease (PACE) study. 
  • Increased body mass index is a risk factor for end-stage renal disease in the Chinese Singapore population. 
  • Increased risk of Staphylococcus aureus bacteremia in hemodialysis-A nationwide study. 
  • Increasing use of vitamin D supplementation in the chronic renal insufficiency cohort study. 
  • Indoxyl sulfate down-regulates SLCO4C1 transporter through up-regulation of GATA3. 
  • Inertia in health care organizations: A case study of peritoneal dialysis services. 
  • Infections after kidney transplantation. Does age matter? 
  • Infective Endocarditis in Patients on Chronic Hemodialysis. 
  • Inflammation and elevated levels of fibroblast growth factor 23 are independent risk factors for death in chronic kidney disease. 
  • Inflammation and the paradox of racial differences in dialysis survival. 
  • Influence of diabetes and perivascular allogeneic endothelial cell implants on arteriovenous fistula remodeling. 
  • Influence of renal function on the use of guideline-recommended therapies for patients with heart failure. 
  • Initial assessment of a new instrument to measure quality of life at the end of life. 
  • Intact parathyroid hormone overestimates the presence and severity of parathyroid-mediated osseous abnormalities in uremia. 
  • Intellectual functioning in renal failure and chronic dialysis. 
  • Intensive glycemic control and the risk of end-stage renal disease: an ADVANCE in the management of diabetes? 
  • Interpreting cardiac troponin results from high-sensitivity assays in chronic kidney disease without acute coronary syndrome. 
  • Intradialytic blood volume monitoring in ambulatory hemodialysis patients: a randomized trial. 
  • Intradialytic hypertension and its association with endothelial cell dysfunction. 
  • Intravenous iron exposure and mortality in patients on hemodialysis. 
  • Is there a clear threshold for fasting plasma glucose that differentiates between those with and without neuropathy and chronic kidney disease?: the Singapore Prospective Study Program. 
  • Ischemic nephropathy and concomitant aortic disease: a ten-year experience. 
  • Kidney allograft survival of African American and Caucasian American recipients with lupus. 
  • Kidney transplantation in HIV-infected patients. 
  • Laparoscopic sleeve gastrectomy improves renal transplant candidacy and posttransplant outcomes in morbidly obese patients. 
  • Leadless Pacemaker Implantation in Hemodialysis Patients: Experience With the Micra Transcatheter Pacemaker. 
  • Life expectancy benefits of cancer screening in the end-stage renal disease population. 
  • Limited health literacy and adverse outcomes among kidney transplant candidates. 
  • Living-related kidney transplant or simultaneous pancreas-kidney for diabetic renal failure? 
  • Long-term incense use and the risk of end-stage renal disease among Chinese in Singapore: the Singapore Chinese health study. 
  • Long-term outcomes in patients with obesity and renal disease after sleeve gastrectomy. 
  • Long-term survival following kidney transplantation in previous lung transplant recipients-An analysis of the unos registry. 
  • Long-term survival for patients with preoperative renal failure undergoing bioprosthetic or mechanical valve replacement. 
  • Longer-term outcomes of darbepoetin alfa versus epoetin alfa in patients with ESRD initiating hemodialysis: a quasi-experimental cohort study. 
  • Longitudinal analysis of market factors associated with provision of peritoneal dialysis services. 
  • Looking at renal failure upside down. 
  • Lower incidence of death from chronic renal disease in patients with nonlethal emphysema: a statistical study. 
  • Lymphocyte depletion and risk of acute rejection in renal transplant recipients at increased risk for delayed graft function. 
  • MELD-XI Score Predicts Early Mortality in Patients After Heart Transplantation. 
  • Macrophage and adipocyte interaction as a source of inflammation in kidney disease. 
  • Management of a cutaneous squamous cell carcinoma overlying an AV fistula. 
  • Management of coronary artery disease in end-stage renal disease. 
  • Managing Heart Failure in Patients on Dialysis: State-of-the-Art Review. 
  • Managing the complications of plasma cell myeloma. 
  • Marijuana and Cannabinoids in ESRD and Earlier Stages of CKD. 
  • Markers of mineral metabolism and vascular access complications: The Choices for Healthy Outcomes in Caring for ESRD (CHOICE) study. 
  • Market Consolidation and Innovation in US Dialysis. 
  • Medical safety in the care of the person with end-stage kidney disease. 
  • Medicare Enrollment Among Patients With End-Stage Kidney Disease Receiving Dialysis in Outpatient Facilities Between 2005 and 2016. 
  • Medicare's New Prospective Payment System on Facility Provision of Peritoneal Dialysis. 
  • Medication Reconciliation: The Foundation of Medication Safety for Patients Requiring Dialysis. 
  • Metastatic complications of bloodstream infections in hemodialysis patients. 
  • Methoxyflurane-induced renal dysfunction. 
  • Microvascular Disease After Renal Transplantation. 
  • Minding the gap and overlap: a literature review of fragmentation of primary care for chronic dialysis patients. 
  • Mineral bone disease in autosomal dominant polycystic kidney disease. 
  • Mitral procedure selection in patients on dialysis: does mitral repair influence outcomes? 
  • Mobile intracardiac calcinosis: risk of thromboembolism in patients with haemodialysed end stage renal disease. 
  • Modelling diabetic nephropathy in mice. 
  • Modifiable risk factors associated with sudden cardiac arrest within hemodialysis clinics. 
  • Morbid prognostic features in patients with chronic liver failure undergoing nonhepatic surgery. 
  • Morphology of coronary atherosclerotic lesions in patients with end-stage renal failure. 
  • Mortality in US Hemodialysis Patients Following Exposure to Wildfire Smoke. 
  • Mortality, kidney disease and cardiac procedures following acute coronary syndrome. 
  • Multi-center experience of 164 consecutive Hemodialysis Reliable Outflow [HeRO] graft implants for hemodialysis treatment. 
  • Multiple bilateral oncocytomas of the native kidneys following renal transplantation: report of a rare case and review of the literature. 
  • Muscle atrophy in patients receiving hemodialysis: effects on muscle strength, muscle quality, and physical function. 
  • Mycotic aneurysm of the thoracoabdominal aorta in a child with end-stage renal disease. 
  • National Academy of Clinical Biochemistry laboratory medicine practice guidelines: use of cardiac troponin and B-type natriuretic peptide or N-terminal proB-type natriuretic peptide for etiologies other than acute coronary syndromes and heart failure. 
  • National Trends in the Association of Race and Ethnicity With Predialysis Nephrology Care in the United States From 2005 to 2015. 
  • Neighborhood socioeconomic status, race, and mortality in young adult dialysis patients. 
  • Net endogenous acid production is associated with a faster decline in GFR in African Americans. 
  • New Treatment Options for Hepatitis C Virus Infection in End-Stage Kidney Disease: To Treat or Not to Treat. 
  • Non-invasive risk assessment in patients with chronic kidney disease. 
  • Nondialytic management of hyperkalemia and pulmonary edema among end-stage renal disease patients: an evaluation of the evidence. 
  • Nontraditional sites for vascular anastomoses to enable kidney transplantation in patients with major systemic venous thromboses. 
  • Nonvitamin K Anticoagulant Agents in Patients With Advanced Chronic Kidney Disease or on Dialysis With AF. 
  • Normalization of hematocrit in hemodialysis patients does not affect silent ischemia. 
  • Normalization of hematocrit in hemodialysis patients with cardiac disease does not increase blood pressure. 
  • Novel once-daily extended-release tacrolimus (LCPT) versus twice-daily tacrolimus in de novo kidney transplants: one-year results of Phase III, double-blind, randomized trial. 
  • Open surgical partial nephrectomy for upper tract urothelial carcinoma. 
  • Opioid Use in Hemodialysis Patients. 
  • Opportunities for improving management of advanced chronic kidney disease. 
  • Optimal timing of hydration to erase contrast-associated nephropathy: the OTHER CAN study. 
  • Oral Anticoagulation and Cardiovascular Outcomes in Patients With Atrial Fibrillation and End-Stage Renal Disease. 
  • Oral Combination Therapies for Hepatitis C Virus Infection: Successes, Challenges, and Unmet Needs. 
  • Oral anticoagulants for stroke prevention in atrial fibrillation: current status, special situations, and unmet needs. 
  • Oral anticoagulation in end-stage renal disease and atrial fibrillation: is it time to just say no to drugs? 
  • Orthopedic complications of renal transplantation in children. 
  • Osteomalacia in chronic renal failure: a syndrome previously reported only with maintenance dialysis. 
  • Outcomes of Staphylococcus aureus infection in hemodialysis-dependent patients. 
  • Pancreas transplantation at the University of Maryland. 
  • Pancreas transplantation at the University of Wisconsin. 
  • Paradoxical embolus following percutaneous thrombectomy of hemodialysis reliable outflow graft. 
  • Paricalcitol, calcitriol, and survival of patients undergoing hemodialysis. 
  • Patient Education and Support During CKD Transitions: When the Possible Becomes Probable. 
  • Patient Preferences for Waiting Time and Kidney Quality. 
  • Patient awareness of chronic kidney disease: trends and predictors. 
  • Patient characteristics, care patterns, and outcomes of atrial fibrillation associated hospitalizations in patients with chronic kidney disease and end-stage renal disease. 
  • Patient-Reported Outcome Instruments for Physical Symptoms Among Patients Receiving Maintenance Dialysis: A Systematic Review. 
  • Patient-reported outcomes in hemodialysis vascular access: A call to action. 
  • Patients with Fabry disease on dialysis in the United States. 
  • Payer Mix Among Patients Receiving Dialysis-Reply. 
  • Pediatric chronic kidney disease in North Carolina. 
  • Perceived susceptibility to chronic kidney disease among high-risk patients seen in primary care practices. 
  • Performance of GFR Slope as a Surrogate End Point for Kidney Disease Progression in Clinical Trials: A Statistical Simulation. 
  • Performance of Indexed and Nonindexed Estimated GFR. 
  • Perioperative Implications of End-stage Renal Disease in Orthopaedic Surgery. 
  • Perioperative outcomes among patients with end-stage renal disease following coronary artery bypass surgery in the USA. 
  • Peripheral neuropathy in patients with chronic renal failure. A treatable source of discomfort and disability. 
  • Peritoneoscopy in the management of catheter malfunction during continuous ambulatory peritoneal dialysis. 
  • Perspectives from the Kidney Health Initiative on Advancing Technologies to Facilitate Remote Monitoring of Patient Self-Care in RRT. 
  • Perspectives on COVID-19 from Singapore: Impact on ESKD Care and Medical Education. 
  • Perspectives on decision making amongst older people with end-stage renal disease and caregivers in Singapore: A qualitative study. 
  • Phosphorus binders and survival on hemodialysis. 
  • Physical activity and risk of end-stage kidney disease in the Singapore Chinese Health Study. 
  • Physician access and early nephrology care in elderly patients with end-stage renal disease. 
  • Physician-diagnosed depression as a correlate of hospitalizations in patients receiving long-term hemodialysis. 
  • Physiological basis of fatigue. 
  • Pilot study of dietary phosphorus restriction and phosphorus binders to target fibroblast growth factor 23 in patients with chronic kidney disease. 
  • Plant protein intake is associated with fibroblast growth factor 23 and serum bicarbonate levels in patients with chronic kidney disease: the Chronic Renal Insufficiency Cohort study. 
  • Plasma-Derived C1 Esterase Inhibitor for Acute Antibody-Mediated Rejection Following Kidney Transplantation: Results of a Randomized Double-Blind Placebo-Controlled Pilot Study. 
  • Pneumocystis carinii pneumonia in renal transplant recipients. 
  • Post transplant CD8+ gammadelta T-cell lymphoma associated with human herpes virus-6 infection. 
  • Postdepletion Lymphocyte Reconstitution During Belatacept and Rapamycin Treatment in Kidney Transplant Recipients. 
  • Postoperative Acute Kidney Injury by Age and Sex: A Retrospective Cohort Association Study. 
  • Postoperative oxycodone toxicity in a patient with chronic pain and end-stage renal disease. 
  • Postparathyroidectomy hypocalcemia as an accurate indicator of preparathyroidectomy bone histology in the uremic patient. 
  • Postprandial mineral metabolism and secondary hyperparathyroidism in early CKD. 
  • Pre-transplant Screening for Non-HLA Antibodies: Who should be Tested? 
  • Predialysis health, dialysis timing, and outcomes among older United States adults. 
  • Predictors of loss of residual renal function among new dialysis patients. 
  • Predictors of short-term changes in serum intact parathyroid hormone levels in hemodialysis patients: role of phosphorus, calcium, and gender. 
  • Predisposition to arrhythmias: electrolytes, uremic fibrosis, other factors. 
  • Preferences for current health and their association with outcomes in patients with kidney disease. 
  • Preoperative Echocardiographic Differences and Transplant Outcomes Among Patients Receiving Simultaneous Liver-Kidney Versus Liver Transplant Alone. 
  • Prescriptions for dietary sodium in patients with chronic kidney disease: how will this shake out? 
  • Prevalence of major depressive episode in CKD. 
  • Preventing bone loss after renal transplantation with bisphosphonates: we can... but should we? 
  • Prevention of contrast media-induced renal dysfunction with prostaglandin E1: a randomized, double-blind, placebo-controlled study. 
  • Primary Medical Care Integrated with Healthy Eating and Healthy Moving is Essential to Reduce Chronic Kidney Disease Progression. 
  • Primary prevention implantable cardioverter defibrillators in end-stage kidney disease patients on dialysis: a matched cohort study. 
  • Procainamide-induced sinus node dysfunction in patients with chronic renal failure. 
  • Prognostic value of troponins in patients with non-ST-segment elevation acute coronary syndromes and chronic kidney disease. 
  • Progressive glomerular toxicity of ifosfamide in children. 
  • Prospective trial of pulse oral versus intravenous calcitriol treatment of hyperparathyroidism in ESRD. 
  • Proteinuria as a modifiable risk factor for the progression of non-diabetic renal disease. 
  • Protocol of the KTFT-TALK study to reduce racial disparities in kidney transplant evaluation and living donor kidney transplantation. 
  • Protocol-based nurse coordinator management of ambulatory tacrolimus dosing in de novo renal transplant recipients-A single-center experience with a large African American population. 
  • Pruritus in systemic disease: mechanisms and management. 
  • Pulse Pressure and the Risk of End-Stage Renal Disease Among Chinese Adults in Singapore: The Singapore Chinese Health Study. 
  • Putting patients at the center of kidney care transitions: PREPARE NOW, a cluster randomized controlled trial. 
  • Quality control of the nutritional component of the Growth Failure in Children with Renal Diseases Study. 
  • Quantifying the risk of incompatible kidney transplantation: a multicenter study. 
  • Quantitation of growth deficits in children with renal diseases. 
  • Race differences in access to health care and disparities in incident chronic kidney disease in the US. 
  • Race, Mineral Homeostasis and Mortality in Patients with End-Stage Renal Disease on Dialysis. 
  • Racial differences in the incidence and progression of renal diseases. 
  • Rates of Medicare Enrollment Among Dialysis Patients After Implementation of Medicare Payment Reform and the Affordable Care Act Marketplace. 
  • Rationale, design, and baseline characteristics of the CArdiovascular safety and Renal Microvascular outcomE study with LINAgliptin (CARMELINA®): a randomized, double-blind, placebo-controlled clinical trial in patients with type 2 diabetes and high cardio-renal risk. 
  • Re-evaluating the volume-outcome relationship in hemodialysis patients. 
  • Recent History of Serious Fall Injuries and Posttransplant Outcomes Among US Kidney Transplant Recipients. 
  • Recent advances in the rapidly evolving field of fibroblast growth factor 23 in chronic kidney disease. 
  • Reconsidering Plant-Based Diets in Patients Receiving Maintenance Hemodialysis. 
  • Red Meat Intake and Risk of ESRD. 
  • Referral and Evaluation for Kidney Transplantation Following Implementation of the 2014 National Kidney Allocation System. 
  • Regional anesthesia for vascular access surgery. 
  • Relation of Baseline Renal Dysfunction With Outcomes in Patients Undergoing Popliteal and Infrapopliteal Percutaneous Peripheral Arterial Interventions. 
  • Relationship Among Viremia/Viral Infection, Alloimmunity, and Nutritional Parameters in the First Year After Pediatric Kidney Transplantation. 
  • Relationship between clinical outcomes and vascular access type among hemodialysis patients with Staphylococcus aureus bacteremia. 
  • Relationship between interdialytic weight gain and blood pressure among prevalent hemodialysis patients. 
  • Relationship between nephrologist care and progression of chronic kidney disease. 
  • Relative risks of chronic kidney disease for mortality and end-stage renal disease across races are similar. 
  • Relevance of B-Lines on Lung Ultrasound in Volume Overload and Pulmonary Congestion: Clinical Correlations and Outcomes in Patients on Hemodialysis. 
  • Religious involvement and health in dialysis patients in Saudi Arabia. 
  • Renal Function and Exercise Training in AmbulatoryHeart Failure Patients With a Reduced Ejection Fraction. 
  • Renal Interstitial Fibrosis: An Imperfect Predictor of Kidney Disease Progression in Some Patient Cohorts. 
  • Renal cell carcinoma suspected at time of organ donation 2008-2016: A report of the OPTN ad hoc Disease Transmission Advisory Committee Registry. 
  • Renal disease in type I glycogen storage disease. 
  • Renal function trajectories and clinical outcomes in acute heart failure. 
  • Renal function, atherothrombosis extent, and outcomes in high-risk patients. 
  • Renal function, concomitant medication use and outcomes following acute coronary syndromes. 
  • Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis. 
  • Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study. 
  • Renal transplantation in adults with thrombotic thrombocytopenic purpura/haemolytic-uraemic syndrome. 
  • Renal transplantation in the American black. 
  • Renal transplantation using belatacept without maintenance steroids or calcineurin inhibitors. 
  • Renin-angiotensin system inhibition in advanced chronic kidney disease: how low can the kidney function go? 
  • Reply: Oral Anticoagulation and Cardiovascular Outcomes in Patients With Atrial Fibrillation and End-Stage Renal Disease. 
  • Research issues in psychological studies of chronic dialysis. 
  • Results of valve replacement with mechanical and biological prostheses in chronic renal dialysis patients. 
  • Retinal arteriolar narrowing increases the likelihood of chronic kidney disease in hypertension. 
  • Retrospective assessment of the utility of an iron-based agent for contrast-enhanced magnetic resonance venography in patients with endstage renal diseases. 
  • Revascularization of the solitary kidney: a challenging problem in a high risk population. 
  • Reversible cardiomyopathies--a review. 
  • Risk factors for renal allograft loss in patients with systemic lupus erythematosus. 
  • Risk factors in necrotizing fasciitis: a case involving Cryptococcus neoformans. 
  • Risk of Infective Endocarditis in Patients with End Stage Renal Disease. 
  • Risk profiles for acute health events after incident atrial fibrillation in patients with end-stage renal disease on hemodialysis. 
  • Risks associated with continuation of potentially inappropriate antihypertensive medications in older adults receiving hemodialysis. 
  • Safety of Intravenous Iron in Hemodialysis: Longer-term Comparisons of Iron Sucrose Versus Sodium Ferric Gluconate Complex. 
  • Safety of low-dose radiocontrast for interventional AV fistula salvage in stage 4 chronic kidney disease patients. 
  • Safety of low-flow sevoflurane anesthesia in patients with chronically impaired renal function is not proven. 
  • Screening for proteinuria in US adults: a cost-effectiveness analysis. 
  • Second Chances to Improve ESRD Outcomes With a Second-Generation Calcimimetic. 
  • Secondary hyperoxaluria: a risk factor for kidney stone formation and renal failure in native kidneys and renal grafts. 
  • Serial Fibroblast Growth Factor 23 Measurements and Risk of Requirement for Kidney Replacement Therapy: The CRIC (Chronic Renal Insufficiency Cohort) Study. 
  • Serious Fall Injuries Before and After Initiation of Hemodialysis Among Older ESRD Patients in the United States: A Retrospective Cohort Study. 
  • Serious Fall Injury History and Adverse Health Outcomes After Initiating Hemodialysis Among Older U.S. Adults. 
  • Serum FGF23 levels in normal and disordered phosphorus homeostasis. 
  • Serum Phosphorus and Progression of CKD and Mortality: A Meta-analysis of Cohort Studies. 
  • Serum Phosphorus and Risk of Cardiovascular Disease, All-Cause Mortality, or Graft Failure in Kidney Transplant Recipients: An Ancillary Study of the FAVORIT Trial Cohort. 
  • Serum electrolyte patterns in end-stage renal disease. 
  • Shared decision-making in end-stage renal disease: a protocol for a multi-center study of a communication intervention to improve end-of-life care for dialysis patients. 
  • Shared patient and provider values in end-stage renal disease decision making: Identifying the tensions. 
  • Short- and long-term outcomes in patients undergoing valve surgery with end-stage renal failure receiving chronic hemodialysis. 
  • Shortening a Carrel Patch in a Graft With Multiple Arteries: A Step-By-Step Technical Analysis. 
  • Should activated vitamin D be used in patients with end-stage renal disease and low levels of parathyroid hormone? 
  • Simplified end stage renal failure risk prediction model for the low-risk general population with chronic kidney disease. 
  • Simultaneous pancreas-kidney transplantation and living related donor renal transplantation in patients with diabetes: is there a difference in survival? 
  • Simultaneous pancreas-kidney transplantation at University of Wisconsin-Madison Hospital. 
  • Simultaneous pancreas-kidney transplantation reduces excess mortality in type 1 diabetic patients with end-stage renal disease. 
  • Simultaneous pancreas/kidney transplantation--a comparison of enteric and bladder drainage of exocrine pancreatic secretions. 
  • Single Measurements of Carboxy-Terminal Fibroblast Growth Factor 23 and Clinical Risk Prediction of Adverse Outcomes in CKD. 
  • Single- and multiple-dose pharmacokinetics of a low-dose oral contraceptive in women with chronic renal failure undergoing peritoneal dialysis. 
  • Single-center experience with renal transplantation in patients with Wegener's granulomatosis. 
  • Site of Care and Health Outcomes of Veterans Undergoing Maintenance Dialysis. 
  • Sleep duration and risk of end-stage renal disease: the Singapore Chinese Health Study. 
  • Slowing the progression of chronic renal insufficiency. 
  • Solid organ transplantation after treatment for childhood cancer: a retrospective cohort analysis from the Childhood Cancer Survivor Study. 
  • Soluble P-selectin levels are associated with cardiovascular mortality and sudden cardiac death in male dialysis patients. 
  • Spectrum of disease in familial focal and segmental glomerulosclerosis. 
  • Spiritual coping, religiosity and quality of life: a study on Muslim patients undergoing haemodialysis. 
  • Splenic Irradiation for the Treatment of Severe Antibody-Mediated Rejection. 
  • Spontaneous hypercalcemia in patients undergoing dialysis. Etiologic and therapeutic considerations. 
  • State medicaid coverage, ESRD incidence, and access to care. 
  • Statins and atherosclerotic cardiovascular outcomes in patients on incident dialysis and with atherosclerotic heart disease. 
  • Statins at Dialysis Transition-Supportive but Not Sufficient. 
  • Statistical Methods for Cohort Studies of CKD: Survival Analysis in the Setting of Competing Risks. 
  • Steady-state pharmacokinetics of lamivudine in human immunodeficiency virus-infected patients with end-stage renal disease receiving chronic dialysis. 
  • Study of Heart and Renal Protection (SHARP): randomized trial to assess the effects of lowering low-density lipoprotein cholesterol among 9,438 patients with chronic kidney disease. 
  • Study protocol of a randomized controlled trial of fistula vs. graft arteriovenous vascular access in older adults with end-stage kidney disease on hemodialysis: the AV access trial. 
  • Subtotal vs. total parathyroidectomy with autotransplantation for patients with renal hyperparathyroidism have similar outcomes. 
  • Sudden Cardiac Death Among Hemodialysis Patients. 
  • Sudden cardiac arrest in ESRD patients. 
  • Sudden cardiac death in hemodialysis patients: a comprehensive care approach to reduce risk. 
  • Supply and Distribution of Vascular Access Physicians in the United States: A Cross-Sectional Study. 
  • Surgical excision of infected arteriovenous grafts: technique and review. 
  • Surgical management of secondary hyperparathyroidism. 
  • Survival among Veterans Obtaining Dialysis in VA and Non-VA Settings. 
  • Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy. 
  • Synergistic effect of chronic kidney disease and high circulatory norepinephrine level on stroke risk in Japanese hypertensive patients. 
  • System for integrated adherence monitoring: real-time non-adherence risk assessment in pediatric kidney transplantation. 
  • Systemic hypertension and nondiabetic chronic kidney disease: the best evidence-based therapeutic approach today. 
  • TRENDS IN THE CARE AND OUTCOMES OF MEDICARE BENEFICIARIES WITH TYPE 2 DIABETES, 2002-2011. 
  • Tacrolimus dose requirements in African-American and Caucasian kidney transplant recipients on mycophenolate and prednisone. 
  • Tailoring the 'Perfect Fit' for Renal Transplant Recipients with End-stage Polycystic Kidney Disease: Indications and Timing of Native Nephrectomy. 
  • Tear urea nitrogen and creatinine levels in renal patients. 
  • Technical innovation. Using a covered stent (wallgraft) to treat pseudoaneurysms of dialysis grafts and fistulas. 
  • Temporal Trends and Outcomes of Implantable Cardioverter Defibrillators in Heart Failure and Chronic Kidney Disease in the United States. 
  • Temporal relation among depression symptoms, cardiovascular disease events, and mortality in end-stage renal disease: contribution of reverse causality. 
  • Temporal trends in the incidence, treatment, and outcomes of hip fracture in older patients initiating dialysis in the United States. 
  • Tertiary excess of fibroblast growth factor 23 and hypophosphatemia following kidney transplantation. 
  • The American Association of Endocrine Surgeons Guidelines for the Definitive Surgical Management of Secondary and Tertiary Renal Hyperparathyroidism. 
  • The Association Between Conversion to In-centre Nocturnal Hemodialysis and Left Ventricular Mass Regression in Patients With End-Stage Renal Disease. 
  • The Economic Burden of Chronic Kidney Disease and End-Stage Renal Disease. 
  • The Effect of Holy Qur'an Recitation on Anxiety in Hemodialysis Patients: A Randomized Clinical Trial. 
  • The Effect of Holy Qur'an Recitation on Depressive Symptoms in Hemodialysis Patients: A Randomized Clinical Trial. 
  • The Incremental Cost of Incompatible Living Donor Kidney Transplantation: A National Cohort Analysis. 
  • The MMPI as a measure of the emotional correlates of chronic hemodialysis: a review. 
  • The Phosphate Binder Ferric Citrate and Mineral Metabolism and Inflammatory Markers in Maintenance Dialysis Patients: Results From Prespecified Analyses of a Randomized Clinical Trial. 
  • The Role of Vitamin D in CKD Stages 3 to 4: Report of a Scientific Workshop Sponsored by the National Kidney Foundation. 
  • The Utility of Basic Metabolic Panel Tests After Total Joint Arthroplasty. 
  • The Utility of Urinalysis in Determining the Risk of Renal Relapse in ANCA-Associated Vasculitis. 
  • The Vexing Problem of Persistent Disparities in Kidney Transplant Care. 
  • The Volume-outcome Relationship in Deceased Donor Kidney Transplantation and Implications for Regionalization. 
  • The association of hepatitis C infection with the onset of CKD and progression into ESRD. 
  • The effect of chronic progressive nephropathy on the incidence of renal tubule cell neoplasms in control male F344 rats. 
  • The effect of frequent hemodialysis on self-reported sleep quality: Frequent Hemodialysis Network Trials. 
  • The effect of the Statewide Sharing variance on geographic disparity in kidney transplantation in the United States. 
  • The effect of vascular access location and size on circuit survival in pediatric continuous renal replacement therapy: a report from the PPCRRT registry. 
  • The effects of adenosine A(1) receptor antagonism in patients with acute decompensated heart failure and worsening renal function: the REACH UP study. 
  • The effects of cytotoxic therapy in progressive IgA nephropathy. 
  • The effects of tenapanor on serum fibroblast growth factor 23 in patients receiving hemodialysis with hyperphosphatemia. 
  • The epidemiology of chronic kidney disease in Northern Tanzania: a population-based survey. 
  • The excess risk of treated end-stage renal disease in blacks in the United States. 
  • The extent and predictors of waiting time geographic disparity in kidney transplantation in the United States. 
  • The frequency of hyperkalemia and its significance in chronic kidney disease. 
  • The impact of anemia on nursing home residents. 
  • The impact of axial spondyloarthritis on quality of life (QoL): a comparison with the impact of moderate to end-stage chronic kidney disease on QoL. 
  • The impact of diabetes on the association between alcohol intake and the risk of end-stage kidney disease in the Singapore Chinese Health Study. 
  • The impact of hepatitis C virus coinfection on HIV-related kidney disease: a systematic review and meta-analysis. 
  • The impact of morbid obesity on resource utilization after renal transplantation. 
  • The impact of slow graft function on graft outcome is comparable to delayed graft function in deceased donor kidney transplantation. 
  • The impact of specific preoperative organ dysfunction in patients undergoing aortic valve replacement. 
  • The influence of various patient characteristics on D-dimer concentration in critically ill patients and its role as a prognostic indicator in the intensive care unit setting. 
  • The joint effects of race and age on the risk of end-stage renal disease attributed to hypertension. 
  • The natural history of renal function following orthotopic heart transplant. 
  • The peritoneal equilibration test in children. 
  • The predictive value of self-report scales compared with physician diagnosis of depression in hemodialysis patients. 
  • The rate of progression of renal disease may not be slower in women compared with men: a patient-level meta-analysis. 
  • The rationale and design of the AASK cohort study. 
  • The relationship between magnitude of proteinuria reduction and risk of end-stage renal disease: results of the African American study of kidney disease and hypertension. 
  • The role of therapeutic apheresis in high immunologic risk renal transplantation: a review of current trends. 
  • The spectrum of ciclosporin nephrotoxicity. 
  • The uneven distribution of kidney transplants: getting at the root causes and improving care. 
  • Therapeutic apheresis in kidney transplantation: a review of renal transplant immunobiology and current interventions with apheresis medicine. 
  • Thoracic complications of peritoneal dialysis. 
  • Thrombosis and the antiphospholipid syndrome. 
  • Timing of commencement of maintenance dialysis and mortality in young and older adults in Singapore. 
  • Topical mupirocin/sodium hypochlorite reduces peritonitis and exit-site infection rates in children. 
  • Traditional Chinese medicine use is associated with lower end-stage renal disease and mortality rates among patients with diabetic nephropathy: a population-based cohort study. 
  • Transcatheter Aortic Valve Replacement in Patients With End-Stage Renal Disease. 
  • Transplantation and autosomal recessive polycystic kidney disease. 
  • Transplantation and the end-stage renal disease program. 
  • Treatment effects of eptifibatide in planned coronary stent implantation in patients with chronic kidney disease (ESPRIT Trial). 
  • Treatment of an acquired Factor XIII inhibitor in an adolescent with systemic lupus erythematosus and renal failure. 
  • Treatment of hepatitis C in special populations. 
  • Treatment of hepatitis C in special populations. 
  • Treatment of hyperkalaemia using intravenous and nebulised salbutamol. 
  • Treatment outcome of late steroid-resistant nephrotic syndrome: a study by the Midwest Pediatric Nephrology Consortium. 
  • Trends in African Americans' Attitudes and Behaviors About Living Donor Kidney Transplantation. 
  • Trends in Peritoneal Dialysis Use in the United States after Medicare Payment Reform. 
  • Trends in Regional Supply of Peritoneal Dialysis in an Era of Health Reform, 2006 to 2013. 
  • Trends in anemia care in older patients approaching end-stage renal disease in the United States (1995-2010). 
  • Trends in multimodal analgesics among end-stage renal disease patients undergoing lower extremity amputation in the US from 2009 to 2018. 
  • Trends in relative mortality between Hispanic and non-Hispanic whites initiating dialysis: a retrospective study of the US Renal Data System. 
  • Trends in the Use of Guideline-Directed Therapies Among Dialysis Patients Hospitalized With Systolic Heart Failure: Findings From the American Heart Association Get With The Guidelines-Heart Failure Program. 
  • Trends in the incidence of atrial fibrillation in older patients initiating dialysis in the United States. 
  • Troponin I and NT-proBNP and the association of systolic blood pressure with outcomes in incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for ESRD (CHOICE) Study. 
  • Twenty years after ACEIs and ARBs: emerging treatment strategies for diabetic nephropathy. 
  • Ultrasound assessment for extravascular lung water in patients undergoing hemodialysis. Time course for resolution. 
  • Underreporting of nursing home utilization on the CMS-2728 in older incident dialysis patients and implications for assessing mortality risk. 
  • Understanding factors that influence the demand for dialysis among elderly in a multi-ethnic Asian society. 
  • Unusual cause of superior vena cava syndrome diagnosed with transesophageal echocardiography. 
  • Update on fibroblast growth factor 23 in chronic kidney disease. 
  • Urine biomarkers of tubular injury do not improve on the clinical model predicting chronic kidney disease progression. 
  • Urological complications and vesicoureteral reflux following pediatric kidney transplantation. 
  • Use of High-Sensitivity Troponin T to Identify Patients With Acute Heart Failure at Lower Risk for Adverse Outcomes: An Exploratory Analysis From the RELAX-AHF Trial. 
  • Use of QT Prolonging Medications by Hemodialysis Patients and Individuals Without End-Stage Kidney Disease. 
  • Usefulness and consequences of cardiac resynchronization therapy in dialysis-dependent patients with heart failure. 
  • Using Zero-Balance Ultrafiltration With Dialysate as a Replacement Solution for Toxin and Eptifibatide Removal on a Dialysis-Dependent Patient During Cardiopulmonary Bypass. 
  • Using renal transplantation to evaluate a simple approach for predicting the impact of end-stage renal disease therapies on patient survival: observed/expected life span. 
  • Utility of the advanced chronic kidney disease patient management tools: case studies. 
  • Utilization of acute care among patients with ESRD discharged home from skilled nursing facilities. 
  • Validation of depression screening scales in patients with CKD. 
  • Validation of the kidney failure risk equation for end-stage kidney disease in Southeast Asia. 
  • Vanishing leg ulcers. 
  • Vascular Calcification Markers and Hemodialysis Vascular Access Complications. 
  • Vitamin D deficiency and anemia in early chronic kidney disease. 
  • Vitamin D deficiency, inflammation, and albuminuria in chronic kidney disease: complex interactions. 
  • Vitamin D levels and early mortality among incident hemodialysis patients. 
  • When All You Have Is a Hammer: The Need for Tools to Define and Apply Patient-Centered Outcomes in Hemodialysis. 
  • When there will never be a randomized controlled trial. 
  • [Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes]. 
• 

  Keywords of People

  • Boulware, L. Ebony, Adjunct Professor in the Department of Medicine, Duke Science & Society
  • Grambow, Steven C., Associate Professor of Biostatistics & Bioinformatics, Biostatistics & Bioinformatics
  • Middleton, John Paul, Professor of Medicine, Medicine, Nephrology
  • Mohottige, Dinushika, Adjunct Assistant Professor in the Department of Medicine, Medicine, Nephrology
  • O'Connor, Christopher Michael, Adjunct Professor in the Department of Medicine, Medicine, Clinical Pharmacology
  • Reed, Shelby Derene, Professor in Population Health Sciences, Duke Science & Society
  • Routh, Jonathan Charles, Paul H. Sherman, M.D. Distinguished Associate Professor of Surgery, Pediatrics